Skip to content

Ocular Trauma and COVID-19 in Indonesia

Ocular Trauma During the COVID-19 Pandemic Era at an Indonesian Tertiary Care Center: A Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06291844
Enrollment
13
Registered
2024-03-04
Start date
2021-01-01
Completion date
2023-06-01
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Ocular Injury, Ophthalmological Disorder

Brief summary

Ocular injuries, a significant contributor to avoidable blindness globally, impact approximately 55 million individuals each year. Prompt initial treatment is vital for improving vision, yet the scarcity of skilled eye specialists often results in overcrowding at advanced medical centers. Moreover, the COVID-19 outbreak has introduced distinct factors into the management of ocular trauma. This research investigated the epidemiology of ocular injuries during the pandemic and offered observations on the distinctive hurdles and trends encountered.

Interventions

None listed

Sponsors

Prof. R. D. Kandou General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Ocular Trauma Patients presenting between January 2021 to March 2022

Exclusion criteria

* Presenting on days outside the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Ocular Trauma2 weeks

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026